Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.51 |
| ▸ | MAOB | P27338 | 3/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 10/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.45 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13311845 | 0.84 | HDAC6 (0.48) | FFAR1FFAR4 | |
| SCHEMBL13311847 | 0.83 | MAOB (0.38) | PPARGMAOBCYSLTR2CYSLTR1PPARD | |
| SCHEMBL6359744 | 0.82 | CYP4F2 (0.51) | CYSLTR2CYSLTR1 | |
| SCHEMBL13348025 | 0.79 | CYP3A4 (0.52) | PPARGMAOBFFAR1FFAR4CYP3A4 | |
| SCHEMBL1587147 | 0.79 | FFAR1 (0.48) | MAOBFFAR1FFAR4 | |
| SCHEMBL10280893 | 0.79 | FFAR1 (0.48) | MAOBFFAR1FFAR4 | |
| SCHEMBL2822420 | 0.79 | FFAR1 (0.48) | MAOBFFAR1FFAR4 | |
| SCHEMBL13311841 | 0.78 | MAOB (0.35) | PPARGMAOBCYSLTR2CYSLTR1PPARD | |
| SCHEMBL1747218 | 0.77 | FFAR1 (0.65) | FFAR1FFAR4 | |
| SCHEMBL1587099 | 0.77 | FFAR1 (0.51) | FFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100152165-A1 | CARBOXYLIC ACID DERIVATIVES | ASTELLAS PHARMA INC. (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100152165-A1 | CARBOXYLIC ACID DERIVATIVES | ASTELLAS PHARMA INC. (JP) | 2010-06-17 | — | — | US | disclosed |
| EP-2096109-A1 | CARBOXYLIC ACID DERIVATIVE | Astellas Pharma Inc. (JP) | 2009-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152165-A1 | CARBOXYLIC ACID DERIVATIVES | GPR119, GPR65, HCAR1 | PPARG 52/4885MAOB 3933/4885FFAR1 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.